SMTL ID : 8gvz.1

Crystal structure of the human dihydroorotase domain in complex with the anticancer drug 5-fluorouracil

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.97 Å

Oligo State

monomer

Ligands

1 x URF: 5-FLUOROURACIL(Non-covalent)

URF.1: 15 residues within 4Å: Chain A: H.18, R.20, N.50, K.101, T.107, F.108, H.135, R.206, D.231, A.233, H.235, P.247, G.248 Ligands: ZN.2, ZN.3 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:H.18, A:R.20, A:R.20, A:N.50, A:T.107 Water bridges: A:T.107, A:T.107 pi-Stacking: A:H.18

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 6 residues within 4Å: Chain A: H.16, H.18, K.101, D.231 Ligands: URF.1, ZN.3 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.16, A:H.18, A:D.231 ZN.3: 5 residues within 4Å: Chain A: K.101, H.135, H.159 Ligands: URF.1, ZN.2 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:H.135, A:H.159

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lin, E.S. et al., Complexed Crystal Structure of the Dihydroorotase Domain of Human CAD Protein with the Anticancer Drug 5-Fluorouracil. Biomolecules (2023)

Release Date

2023-09-20

Peptides

CAD protein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CAD protein

Related Entries With Identical Sequence